Clinical Trials Browser

Phase 2 × Hematologic Neoplasms × duvelisib × Clear all

NCT02711852 2023-09-11

A Long-term, Continued Treatment and Follow-up Study in Participants With Hematologic Malignancies Treated With Duvelisib (IPI-145)

Phase 2 Completed

19 enrolled 11 charts

Other hematologic neoplasm

Hematologic Neoplasms